Stay updated on iSCORE Immunotherapy Sequencing Clinical Trial

Sign up to get notified when there's something new on the iSCORE Immunotherapy Sequencing Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the iSCORE Immunotherapy Sequencing Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The iSCORE study record for metastatic colorectal cancer is now displayed instead of an access-denied page, with details about the Nivolumab and Relatlimab trial, participant eligibility, and study outcomes.
    Difference
    46%
    Check dated 2026-11-08T05:59:02.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.3%
    Check dated 2026-11-01T03:58:37.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The page content below remains a 403 error.
    Difference
    1%
    Check dated 2026-10-25T04:24:43.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T03:58:07.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T05:11:14.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with the site header and footer, indicating the study record is currently inaccessible rather than a substantive content update.
    Difference
    18%
    Check dated 2026-09-20T02:37:50.000Z thumbnail image

Stay in the know with updates to iSCORE Immunotherapy Sequencing Clinical Trial

Enter your email address, and we'll notify you when there's something new on the iSCORE Immunotherapy Sequencing Clinical Trial page.